Stephen Hoge, President at Moderna, Inc. (MRNA), sold 341 shares at $144.50 ($49K) on 2024-05-29, disclosed to the SEC on 2024-05-30.
Seasonal sale ($49k) by President — this insider has traded MRNA in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |
| MRNA | SELL | 2026-02-25 | $7.8M | — | Filing → |